CompletedNCT00736255
Lisdexamfetamine or placebo added to nicotine patches for smoking cessation in adults with ADHD
About this title
Read the official source — NCT00736255Medication studyAges 18–50United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 50 years.
- Listed locations
- DurhamSee all locations and recruitment
Study information
Study start dateDecember 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 32
- Sponsor
- Duke University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 18 Years to 50 Years
- Official registry ID
- NCT00736255
- Official title
Show the full official title
Lis-dexamphetamine (LDX/SPD489)as a Treatment for Smoking Cessation in Nicotine Dependent Individuals With ADHD
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Durham
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Duke University, a university.
Did this study involve medication?
Yes. The study involved medication, including Transdermal Nicotine Patch, Lis-dexamphetamine (Vyvanse) and Placebo.
Who was this study for?
Listed age limits: 18 years to 50 years.
